Chair Aditya Bardia, MD, MPH, FASCO, discusses breast cancer in this CME/MOC/CC/NCPD/AAPA/IPCE activity titled “Empowering Changes and Revolutionizing Treatment and Equity in Breast Cancer: Unlocking the Potential of Adjuvant CDK4/6 Inhibitors to Reduce the Risk of Recurrence and Improve Outcomes for Diverse Patient Populations With HR+/HER2- Early Breast Cancer.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3EVXyo9. CME/MOC/CC/NCPD/AAPA/IPCE credit will be available until January 25, 2025.